Related Experiment Video
Updated: Jun 6, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Computer-aided dosage in oral anticoagulation therapy using phenprocoumon. Problems and approaches
1Lehrstuhl Mathematik, insbesondere Numerische und Angewandte Mathematik, Postfach 101344, 03013 Cottbus, Germany. cromme@tu-cottbus.de
Hamostaseologie
|November 9, 2010
Summary
Computer-aided systems can improve oral anticoagulation management. This study validates mathematical models for expert systems to enhance the safety of vitamin K antagonist therapy and prevent thromboembolic events.
Area of Science:
- Pharmacology
- Medical Informatics
Background:
- Oral anticoagulation with vitamin K antagonists (VKAs) is a long-established therapy for preventing thromboembolic incidents.
- Despite its efficacy, therapeutic control of VKA treatment remains challenging due to issues like interpreting International Normalized Ratio (INR) measurements and dosage adjustments.
Purpose of the Study:
- To address the difficulties in managing VKA therapy, this study aims to validate mathematical models for a computer-aided expert system.
- The goal is to enhance the safety and therapeutic control of oral anticoagulation.
Main Methods:
- The study involves validating mathematical models intended for use in a computer-aided expert system for VKA dosage.
- Preliminary results from this validation study are presented.
Main Results:
- The study presents preliminary findings on the validation of mathematical models for VKA management.
- These models are foundational for developing expert systems to aid physicians.
Conclusions:
- A computer-aided expert system holds promise for improving the safety of oral anticoagulation therapy.
- Validating the underlying mathematical models is crucial for the reliable implementation of such systems in clinical practice.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...